The race against time to disclose lung inflammation in interstitial lung disease in systemic sclerosis: is PET scan the winning solution?
- PMID: 32159796
- PMCID: PMC7850146
- DOI: 10.1093/rheumatology/keaa077
The race against time to disclose lung inflammation in interstitial lung disease in systemic sclerosis: is PET scan the winning solution?
Comment on
-
The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.Rheumatology (Oxford). 2020 Jun 1;59(6):1407-1415. doi: 10.1093/rheumatology/kez483. Rheumatology (Oxford). 2020. PMID: 31642912 Free PMC article.
References
-
- Varga J, Trojanowska M, Kuwana M.. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat Disord 2017;2:137–52.
-
- Lee JS, Im JG, Ahn JM. et al. Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT. Radiology 1992;184:451–4. - PubMed
-
- Volkmann ER, Chung A, Tashkin DP.. Tashkin DP Managing systemic sclerosis-related interstitial lung disease in the modern treatment era. J Scleroderma Relat Disord 2017;2:72–83.
-
- Umeda Y, Demura Y, Ishizaki T. et al. Dual-time-point 18F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia. Eur J Nucl Med Mol Imaging 2009;36:1121–30. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
